Merck (MRK) Tops Q3 EPS by 7c; narrows guidance range
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $115.48 +1.41%
Revenue Growth %: +3.5%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +3.5%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q3 EPS of $1.57, $0.07 better than the analyst estimate of $1.50. Revenue for the quarter came in at $16.66 billion versus the consensus estimate of $16.45 billion.
GUIDANCE:
Merck sees FY2024 EPS of $7.72-$7.77, versus the consensus of $7.74. Merck sees FY2024 revenue of $63.6-64.1 billion, versus the consensus of $64.15 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- BuzzFeed sells shares to Byron Allen affiliate for $5.8 million
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
